Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00016796 · ClinicalTrials.gov registry record

Language Stimuli Screening in Children

A clinical trial of Healthy and Language Disorder, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
150
Enrollment target
1
Study location

NCT00016796: Completed study of Healthy and Language Disorder, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00016796 is a study of Healthy and Language Disorder that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 150 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00016796, a study of Healthy and Language Disorder, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

This study will determine baseline language skills in children 4 to 8 years old. The data will be used to design studies using functional magnetic resonance imaging (fMRI) to identify what areas of the brain in children are involved in understanding language. This information is important for children who require brain surgery to control seizures. Healthy normal volunteers between the ages of 4 and 8 years who have an IQ of 70 or more; who have no history of neurologic, psychiatric or language disorder; who are performing at or above grade level, and who are native English speakers may be eligible for this study. Participants will be asked to do the following: * name pictures or read words that appear on a computer screen * listen to stories and answer questions about them * match pictures to a spoken word The children's responses will be recorded.

Study Locations (1)

Maryland

  • National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2001-05
Est. Completion 2005-03

What the finished NCT00016796 record still lists

NCT00016796 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT00016796 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00016796 about?

NCT00016796 is a clinical study titled "Language Stimuli Screening in Children". This study will determine baseline language skills in children 4 to 8 years old. The data will be used to design studies using functional magnetic resonance imaging (fMRI) to identify what areas of the brain in children are involved in understanding language. This information is important for childr...

What is the current status of trial NCT00016796?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2001-05. Estimated completion is 2005-03.

What conditions does trial NCT00016796 study?

This clinical trial studies the following conditions: Healthy, Language Disorder.

Who is sponsoring clinical trial NCT00016796?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00016796 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00016796's enrollment target sits among peer trials

150 152nd of 1090 higher than 935 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00016796, the US trial registry maintained by the National Library of Medicine. NCT00016796 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.